Skip to main content
SpringerLink
Log in

Left ventricular hypertrophy deserves attention as an independent risk factor for cardiovascular events

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Teo KK. Risk and management of hypertension-related left ventricular hypertrophy. Drugs 1995 Dec; 50(6): 959–70

    Article  PubMed  CAS  Google Scholar 

  2. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA 1994 Jul 6; 272(1): 33–6

    Article  PubMed  CAS  Google Scholar 

  3. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. Am J Hypertension 1992 Feb; 5(2): 95–110

    Google Scholar 

  4. Chambers J. Left ventricular hypertrophy [editorial]. BMJ 1995 Jul 29; 311: 273–4

    Article  PubMed  CAS  Google Scholar 

  5. Levy D, Salomon M, D’Agostino RB, et al. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786–93

    Article  PubMed  CAS  Google Scholar 

  6. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985 Jul 13; 291: 97–104

    Article  Google Scholar 

  7. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992 Feb 15; 304: 405–12

    Article  Google Scholar 

  8. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991 Jun 26; 265(24): 3255–64

    Article  Google Scholar 

  9. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993 Jan 25; 153: 154–83

    Article  Google Scholar 

  10. Sever P, Beevers G, Bulpitt C, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993 Apr 10; 306: 983–7

    Article  PubMed  CAS  Google Scholar 

  11. Higgins G. News from the 6th International Symposium on Cardiovascular Pharmacotherapy. Inpharma 1996 Mar 16; (1028): 12

  12. Psaty BM, Heckbert SR, Koepsall TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995 Aug 23–30; 274: 620–5

    Article  PubMed  CAS  Google Scholar 

  13. Pahor M, Guralnik JM, Corti M-C, et al. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995 Nov; 42: 1191–7

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Left ventricular hypertrophy deserves attention as an independent risk factor for cardiovascular events. Drugs Ther. Perspect 7, 8–10 (1996). https://doi.org/10.2165/00042310-199607090-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607090-00003

Search

Navigation